研究生分子生物學(xué)工作基礎(chǔ)新基因研究路線課件_第1頁(yè)
研究生分子生物學(xué)工作基礎(chǔ)新基因研究路線課件_第2頁(yè)
研究生分子生物學(xué)工作基礎(chǔ)新基因研究路線課件_第3頁(yè)
研究生分子生物學(xué)工作基礎(chǔ)新基因研究路線課件_第4頁(yè)
研究生分子生物學(xué)工作基礎(chǔ)新基因研究路線課件_第5頁(yè)
已閱讀5頁(yè),還剩32頁(yè)未讀, 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

LossofFunction

InhibitionofactivityInhibitionofexpressionInhibitionofActivitySpecificinhibitorsDominantnegativesSpecificantibodiesHistoneDeacetylase(HDAC)inhibitorsHistonedeacetylaseinhibitorsandthepromiseofepigenetic(andmore)treatmentsforcancer.NatureReviewsCancer.2019Vol6.38-51DominantNegativeAmutationwhosegeneproductadverselyaffectsthenormal,wild-typegeneproductwithinthesamecell.Thisusuallyoccursiftheproductcanstillinteractwiththesameelementsasthewild-typeproduct,butblocksomeaspectofitsfunction.Examples:

1.Amutationinatranscriptionfactorthatremovestheactivationdomain,butstillcontainstheDNAbindingdomain.Thisproductcanthenblockthewild-typetranscriptionfactorfrombindingtheDNAsiteleadingtoreducedlevelsofgeneactivation.

2.Aproteinthatisfunctionalasadimer.Amutationthatremovesthefunctionaldomain,butretainsthedimerizationdomainwouldcauseadominatenegativephenotype,becausesomefractionofproteindimerswouldbemissingoneofthefunctionaldomains.

DominantnegativemutantofatranscriptionfactorpolIIPPPInhibitionofExpressionRNAinterference(RNAi)Knockout

RNAINTERFERENCE(RNAi)

AndrewZ.FireandCraigC.Mello

"fortheirdiscoveryofRNAinterference-genesilencingbydouble-strandedRNA".–NobelPrizeinPhysiologyandMedicine2019AndrewFire,SiQunXu,MaryK.Montgomery,StevenA.Kostas,SamuelE.Driver,CraigC.Mello.Potentandspeci?cgeneticinterferencebydouble-strandedRNAinCaenorhabditiselegans

Nature391:806–811,2019RNAiinMammaliancells

>30basepairdouble-strandedRNA

ShortinterferingRNAs<30basepairsPKRinactivePKRactive2’,5’-ASinactive2’,5’-ASactiveDegradationofmRNA(Sequence-specificeffects)(Globaleffects)Cleavage

Inhibitionofproteinsynthesis

DegradationofmRNAsRNAiEndogenousSRC-1RNAi

5’

C

C

U

C

A

G

G

G

C

A

G

A

G

A

A

C

C

A

U

C

U

T

T

T

T

G

G

A

G

U

C

C

C

G

U

C

U

C

U

U

G

G

U

A

G

A5’

19439634365SRC-1mRNASmallinterferingRNA(siRNA)AIB1GRIP1LaminALaminCSRC-1siRNALaminsiRNABufferSRC-1SRC-1siRNALaminAsiRNABufferBuffer

b-gallacZSRC-1siRNALaminsiRNABufferSRC-1siRNALaminsiRNABufferSRC-1siRNALaminsiRNABuffer-++

+Shang,Y.,andBrown,M.Science

295:2465-2468,2019MechanismsInvolvedinRNAiRNaseIIIfamilymembersareamongthefewnucleasesthatshowspecificityfordsRNA.AnalysisoftheDrosophilaandC.elegansgenomesreveals3typesofRNaseIIIenzymes.thecanonicalRNaseIII,whichcontainsasingleRNaseIIIsignaturemotifandadsRNA-bindingdomain(dsRBD;forexampleRNC_CAEEL).Drosha,aDrosophilaenzymethatcontainstwoRNaseIIImotifsandadsRBD.HomelesscontainstwoRNaseIIIsignaturesandanamino-terminalhelicasedomain(DrosophilaCG4792andCG6493;C.elegansK12H4.8)TheDiscoveryofDicerDicerFamilyDrosophila:DicerC.elegans:K12H4.8Arabidopsis:CARPELFACTORY,T25K16.4andAC012328_1)Mammals:Helicase-MOISchizosaccharomycespombe:YC9A_SCHPORNAi

anATP-dependent

ProcessBasedupontheknownmechanismsfortheRNaseIIIfamilyofenzymes,Diceristhoughttoworkasadimericenzyme.CleavageintopreciselysizedfragmentsisdeterminedbythefactthatoneoftheactivesitesineachDicerproteinisdefective,shiftingtheperiodicityofcleavagefrom9–11nucleotidesforbacterialRNaseIIIto22nucleotidesforDicerfamilymembers.MethodsofRNAiknockdowninmammaliancells

SchematicofthesiRNAmediatedRNAinterferencepathway.Afterentryintothecytoplasm,siRNAiseitherloadedontoRISCdirectlyorutilizeaDicermediatedprocess.AfterRISCloading,thepassengerstranddeparts,therebycommencingtheRNAinterferenceprocessviatargetmRNAcleavageanddegradation.siRNAloadedRISCsarealsofoundtobeassociatedwithnucleolusregionandmaybeshuttledinandoutofnucleusthroughanyetunidentifiedprocess.siRNAvs.shRNA:Similaritiesanddifferences.AdvancedDrugDeliveryReviews61(2009)746–759

SchematicoftheshRNAmediatedRNAinterferencepathway.AfterdeliveryoftheshRNAexpressionvectorintothecytoplasm,thevectorneedstobetransportedintothenucleusfortranscription.Theprimarytranscripts(pre-shRNA)followasimilarrouteasdiscoveredfortheprimarytranscriptsofmicroRNA.TheprimarytranscriptsareprocessedbytheDrosha/DGCR8complexandformpreshRNAs.Pre-shRNAsaretransportedtothecytoplasmviaexportin5,tobeloadedontotheDicer/TRBP/PACTcomplexwheretheyarefurtherprocessedtomatureshRNA.MatureshRNAintheDicer/TRBP/PACTcomplexareassociatedwithArgonauteproteincontainingRISCandprovideRNAinterferencefunctioneitherthroughmRNAcleavageanddegradation,orthroughtranslationalsuppressionviap-bodies.TheSpecificityofRNAiifsiRNAselicitaspecificresponse,thenallofthesiRNAsdesignedagainstthesametargetwouldbeexpectedtoproducesimilargeneexpressionsignaturesthesiRNAsdesignedagainstdifferenttargetgeneswouldbeexpectedtoshowdifferentgeneexpressionsignaturesImportantParametersinsiRNATransfectionExperiments

HealthofculturedcellsTransfectionmethod Adherentmammaliancellshavebeentraditionallypre-platedintotissueculturewellsandallowedtoattach,recover,andgrowfor24hpriortotransfection.Reversetransfectionisanalternativemethodoftransfectionwherecellsaretransfectedwhilestillinsuspension(i.e.aftertrypsinizationandpriortoplating).Reversetransfectionisbelievedtoincreasecellexposuretotransfectioncomplexesoftenleadingtogreatertransfectionefficiency.Transfectionconditions LengthofcellexposuretotransfectionagentsshouldbeoptimizedtominimizecellulartoxicityandmaximizesiRNAactivitybyvaryingtheamountoftransfectionagentandcellexposuretimetotransfectioncomplexes.QualityandquantityofsiRNAzh.invitrogen/site/cn/zh/home/References/Ambion-Tech-Support/rnai-sirna/tech-notes/optimizing-sirna-transfection-for-rnai.html

SummaryofDifferentsiRNADeliveryMethodsGeneKnockout

(9-12months)CloningandmappingofmousegenomictargetDNAfromamousecDNAsequence(3-5weeks)Designingandcreatingatargetingvector(6-10weeks)ElectroporationandselectionofEScells(6-10weeks)IdentificationofhomologousrecombinantESclones(2weeks)Expansionofrecombinantclones(1weeks)BlastocystinjectionofrecombinantESclones(4-6weeks)Identificationofgermlinetransmission(10-12weeks)ConfirmationofgermlinetransmissionbyPCR(2weeks)KnockoutvsKnock-inPhenotypicalReadoutsAnimalgrowthanddevelopmentSystem/organ/tissuegrowthanddevelopmentCellularlevelgrowthandproliferationmorphologyandotherbehaviorallychangesmetabolicchangesMolecularLevelchangesintargetgeneexpressionchangesinsignaltransductionpathwayseffectsondownstreamgenesFunctionalAnalysisofGenesSequenceandstructureanalysisExpressionprofilingCellularcompartmentalizationGain-of-functionLoss-of-functionProtein-proteininteractionUpstreamcuesDownstreameffectsProtein-ProteinInteractionCo-immunoprecipitationGSTpull-downFluorescentimagingCo-fractionationFRAPFRETImmunoprecipitationCo-Immnunoprecipitation(co-IP)Co-IPOptimizationStrategiesComplexbindingUselysisandwashbufferswithlowionicstrength(i.e.,<120mMNaCl)thatcontainnon-ionicdetergents(NP-40andTritonX-100),whichareless

溫馨提示

  • 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

最新文檔

評(píng)論

0/150

提交評(píng)論